Susquehanna International Group’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-306
Closed -$6.42K 6695
2025
Q1
$6.42K Sell
306
-102
-25% -$2.14K ﹤0.01% 6240
2024
Q4
$10.2K Buy
+408
New +$10.2K ﹤0.01% 6044
2024
Q3
Hold
0
5972
2024
Q2
Sell
-5,546
Closed -$1.66M 6000
2024
Q1
$1.66M Buy
5,546
+4,431
+397% +$1.33M ﹤0.01% 2035
2023
Q4
$263K Buy
+1,115
New +$263K ﹤0.01% 4676
2023
Q3
Sell
-421
Closed -$73.2K 5860
2023
Q2
$73.2K Sell
421
-500
-54% -$86.9K ﹤0.01% 5111
2023
Q1
$116K Sell
921
-415
-31% -$52.3K ﹤0.01% 5183
2022
Q4
$405K Buy
+1,336
New +$405K ﹤0.01% 3494
2022
Q3
Sell
-176
Closed -$11K 6427
2022
Q2
$11K Sell
176
-300
-63% -$18.8K ﹤0.01% 5488
2022
Q1
$54K Sell
476
-2,176
-82% -$247K ﹤0.01% 5299
2021
Q4
$382K Buy
2,652
+1,848
+230% +$266K ﹤0.01% 4173
2021
Q3
$176K Buy
804
+213
+36% +$46.6K ﹤0.01% 4768
2021
Q2
$137K Buy
591
+24
+4% +$5.56K ﹤0.01% 4986
2021
Q1
$171K Buy
567
+113
+25% +$34.1K ﹤0.01% 4850
2020
Q4
$171K Sell
454
-174
-28% -$65.5K ﹤0.01% 4330
2020
Q3
$193K Buy
628
+320
+104% +$98.3K ﹤0.01% 3902
2020
Q2
$116K Buy
308
+89
+41% +$33.5K ﹤0.01% 3885
2020
Q1
$50K Buy
219
+88
+67% +$20.1K ﹤0.01% 4213
2019
Q4
$69K Sell
131
-389
-75% -$205K ﹤0.01% 3733
2019
Q3
$224K Sell
520
-498
-49% -$215K ﹤0.01% 3736
2019
Q2
$1.21M Buy
1,018
+824
+425% +$983K ﹤0.01% 1808
2019
Q1
$241K Buy
+194
New +$241K ﹤0.01% 2415
2018
Q4
Hold
0
4106
2018
Q3
Hold
0
3863
2018
Q2
Hold
0
4029
2018
Q1
Sell
-1,780
Closed -$2.99M 3801
2017
Q4
$2.99M Buy
1,780
+614
+53% +$1.03M ﹤0.01% 855
2017
Q3
$1.63M Buy
1,166
+234
+25% +$328K ﹤0.01% 1248
2017
Q2
$1.04M Buy
+932
New +$1.04M ﹤0.01% 1748